167 related articles for article (PubMed ID: 7584665)
21. Characterization of the alpha subunit of the IFN-alpha receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins.
Platanias LC; Pfeffer LM; Cruciani R; Colamonici OR
J Immunol; 1993 Apr; 150(8 Pt 1):3382-8. PubMed ID: 8468477
[TBL] [Abstract][Full Text] [Related]
22. Localization of the receptor binding site of IFN-alpha 2b.
Siemers R; Hensley L; Ozer H
J Immunol; 1988 Sep; 141(5):1550-5. PubMed ID: 2970505
[TBL] [Abstract][Full Text] [Related]
23. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
24. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
Chill JH; Quadt SR; Anglister J
Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
[TBL] [Abstract][Full Text] [Related]
25. Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative activities.
Redlich PN; Grossberg SE
Eur J Immunol; 1990 Sep; 20(9):1933-9. PubMed ID: 1698636
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human type I interferon receptor by ligand blotting.
Schwabe M; Princler GL; Faltynek CR
Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
[TBL] [Abstract][Full Text] [Related]
27. The human interferon alpha/beta receptor: characterization and molecular cloning.
Novick D; Cohen B; Rubinstein M
Cell; 1994 May; 77(3):391-400. PubMed ID: 8181059
[TBL] [Abstract][Full Text] [Related]
28. Immunochemical mapping of alpha-2 interferon.
Lydon NB; Favre C; Bove S; Neyret O; Benureau S; Levine AM; Seelig GF; Nagabhushan TL; Trotta PP
Biochemistry; 1985 Jul; 24(15):4131-41. PubMed ID: 2413884
[TBL] [Abstract][Full Text] [Related]
29. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
30. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I; Krchnák V
J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
[TBL] [Abstract][Full Text] [Related]
31. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
Kumaran J; Colamonici OR; Fish EN
J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
[TBL] [Abstract][Full Text] [Related]
32. Epitope mapping of human recombinant interferon alpha molecules by monoclonal antibodies.
Alkan SS; Braun DG
Ciba Found Symp; 1986; 119():264-78. PubMed ID: 2426055
[TBL] [Abstract][Full Text] [Related]
33. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
[TBL] [Abstract][Full Text] [Related]
34. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN.
Adolf GR
Virology; 1990 Apr; 175(2):410-7. PubMed ID: 1691561
[TBL] [Abstract][Full Text] [Related]
36. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence.
Subramaniam PS; Johnson HM
FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821
[TBL] [Abstract][Full Text] [Related]
37. Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells.
Overall ML; Chambers P; Hertzog PJ
J Interferon Res; 1992 Aug; 12(4):281-8. PubMed ID: 1431308
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of a high affinity binding site for type I interferons.
Russell-Harde D; Pu H; Betts M; Harkins RN; Perez HD; Croze E
J Biol Chem; 1995 Nov; 270(44):26033-6. PubMed ID: 7592797
[TBL] [Abstract][Full Text] [Related]
39. Generation and characterization of anti-idiotypic antibodies recognizing the interferon-alpha receptor: implications for ligand-receptor interactions.
Lim JK; Langer JA
J Interferon Res; 1993 Aug; 13(4):295-301. PubMed ID: 7693831
[TBL] [Abstract][Full Text] [Related]
40. Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.
Arnheiter H; Ohno M; Smith M; Gutte B; Zoon KC
Proc Natl Acad Sci U S A; 1983 May; 80(9):2539-43. PubMed ID: 6302694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
